WASHINGTON — A bipartisan group of seven former FDA Commissioners are uniting to advocate for breaking the Food and Drug Administration out of the Department of Health and Human Services and making it an independent agency.

The idea is to make the FDA less vulnerable to political pressure, so it can focus instead on protecting public health. While FDA’s mission has always been politicized, the issue is particularly salient now given President Trump’s propensity for pressuring the agency to prioritize politically popular policies. Current commissioner Scott Gottlieb has been a good soldier for that effort, even implementing the Right to Try pathway that previous commissioners said would “create a dangerous precedent.”

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy